Literature DB >> 23535752

Clinicopathologic significance of histologic grade, pgp, and p53 expression in canine lymphoma.

Ravinder S Dhaliwal1, Barbara E Kitchell, Ej Ehrhart, Victor E Valli, Nikolaos G Dervisis.   

Abstract

To characterize the expression of P-glycoprotein (Pgp) and p53 in different histologic grades of canine multicentric lymphosarcoma (LSA), 31 cases of LSA without prior treatment were studied. The expression levels of the Pgp and p53 proteins were evaluated for their clinicopathologic significance among standard histologic evaluation. Immunohistochemistry (IHC) was performed on formalin-fixed, paraffin-embedded archival samples of 31 previously untreated LSA cases to detect the expression of Pgp and p53. All dogs were subsequently treated with a combination chemotherapy protocol. Remission and survival durations were evaluated for correlation with histologic grade and presence of drug resistance markers. Of the 31 cases, 24 (80%) and 7 (22%) were positive for Pgp and p53, respectively. Overall, the median survival and duration of remission in the study was 246 days and 137 days, respectively. The National Cancer Institute working formulation histologic grade was not associated with either survival or duration of first remission (DOR). The Pgp protein expression and DOR and survival was not statistically significant. Expression of p53 was statistically correlated with survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535752     DOI: 10.5326/JAAHA-MS-5843

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  4 in total

Review 1.  Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma.

Authors:  Hirotaka Tomiyasu; Hajime Tsujimoto
Journal:  Vet Sci       Date:  2015-08-12

Review 2.  Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Authors:  Maurice Zandvliet; Erik Teske
Journal:  Vet Sci       Date:  2015-08-12

3.  P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

Authors:  Valéria Dékay; Edina Karai; András Füredi; Kornélia Szebényi; Gergely Szakács; Péter Vajdovich
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

4.  Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.

Authors:  A Koshino; Y Goto-Koshino; A Setoguchi; K Ohno; H Tsujimoto
Journal:  J Vet Intern Med       Date:  2015-12-17       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.